Overactive bladder symptoms after midurethral sling surgery in women: Risk factors and management

Erectile and Sexual Functions and DysfunctionsOveractive Bladder

Does the Severity of Overactive Bladder Symptoms Correlate With Risk for Female Sexual Dysfunction?

J Sex Med.

Juliato CRT, Melotti IGR, Junior LCS, Britto LGO, Riccetto CLZ

doi: 10.1016/

Overactive Bladder

Management of Overactive Bladder in Older Women

Curr Urol Rep.

Pratt TS, Suskind AM

doi: 10.1007/s11934-018-0845-5.

Urinary Incontinence

Long-term Rate of Mesh Sling Removal Following Midurethral Mesh Sling Insertion Among Women With Stress Urinary Incontinence

JAMA.

Gurol-Urganci I, Geary RS, Mamza JB, Duckett J, El-Hamamsy D, Dolan L, Tincello DG, van der Meulen J

doi: 10.1001/jama.2018.14997.

Benign Prostatic Hyperplasia (BPH)Lower Urinary Tract SymptomsOveractive Bladder

Nerve growth factor levels are associated with overactive bladder symptoms and long-term treatment outcome after transurethral resection of the prostate in patients with benign prostate hyperplasia

J Urol.

Hu H, Zhang W, Liu X, Wang H, Fang Z, Liang C, Wang T, Xu K

doi: 10.1016/j.juro.2018.03.130.

Lower Urinary Tract SymptomsOveractive Bladder

Clinical Efficacy of Solifenacin in the Management of Diabetes Mellitus-Associated Versus Idiopathic Overactive Bladder Symptoms: A Multicenter Prospective Study

Int Neurourol J.

Choi H, Bae JH, Oh CY, Jeong SJ, Ko WJ, Choi JB, Seo JT, Lee DH, Kim JC, Lee KW, Kim YH

doi: 10.5213/inj.1834982.491.

Overactive Bladder

Beyond the bladder: poor sleep in women with overactive bladder syndrome

Am J Obstet Gynecol.

Savoie MB, Lee KA, Subak LL, Hernandez C, Schembri M, Fung CH, Grady D, Huang AJ

doi: 10.1016/j.ajog.2019.12.005.

Urinary Incontinence

Characteristics Associated With Treatment Failure 1 Year After Midurethral Sling in Women With Mixed Urinary Incontinence

Obstet Gynecol.

Sung VW, Richter HE, Moalli P, Weidner AC, Nguyen JN, Smith AL, Dunivan G, Ridgeway B, Borello-France D, Newman DK, Mazloomdoost D, Carper B, Gantz MG, Eunice Kennedy Shriver National Institute of Child Health and Human Development Pelvic Floor Disorders Network*.

doi: 10.1097/AOG.0000000000003989.

Overactive BladderUrinary Incontinence

Retrospective analysis in 46 women with vulvovaginal atrophy treated with ospemifene for 12 weeks: improvement in overactive bladder symptoms

Gynecol Endocrinol.

Schiavi MC, Zullo MA, Faiano P, D'Oria O, Prata G, Colagiovanni V, Giannini A, Di Tucci C, Perniola G, Di Donato V, Monti M, Muzii L, Benedetti Panici P

doi: 10.1080/

Risk Factors for Microscopic Hematuria in Women

Female Pelvic Med Reconstr Surg.

Richter LA, Lippmann QK, Jallad K, Lucas J, Yeung J, Dune T, Mellano E, Weissbart S, Mete M, Kim JH, Gutman R

doi: 10.1097/SPV.

Related content